IS THE ELTROMPOBAG TREATMENT SAFE OR EFFECTIVE FOR REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA PATIENTS?

Basit Öğe Kaydı
dc.contributor.authorDal, M.
dc.contributor.authorKarakus, A.
dc.contributor.authorCakar, M.
dc.contributor.authorUlu, B.
dc.contributor.authorHattapoglu, E.
dc.contributor.authorEkmen, M.
dc.contributor.authorUlas, T.
dc.date.accessioned2024-04-24T17:47:45Z
dc.date.available2024-04-24T17:47:45Z
dc.date.issued2016
dc.departmentDicle Üniversitesien_US
dc.description7th International Eurasian Hematology Congress -- OCT 13-16, 2016 -- Istanbul, TURKEYen_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpageS44en_US
dc.identifier.issn0145-2126
dc.identifier.issn1873-5835
dc.identifier.startpageS44en_US
dc.identifier.urihttps://hdl.handle.net/11468/22728
dc.identifier.volume49en_US
dc.identifier.wosWOS:000391180600109
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.ispartofLeukemia Research
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleIS THE ELTROMPOBAG TREATMENT SAFE OR EFFECTIVE FOR REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA PATIENTS?en_US
dc.titleIS THE ELTROMPOBAG TREATMENT SAFE OR EFFECTIVE FOR REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA PATIENTS?
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu